Skip to main content
. 2017 Aug 12;8(45):78734–78748. doi: 10.18632/oncotarget.20223

Table 1. Association between RASSF7 expression and clinicopathologic factors in NSCLC.

Characteristics N Overall expression Cytoplasmic expression Nuclear expression
low high P low high P low high P
Age
 < 60 (years) 35 8 27 0.706 10 25 0.595 31 4 0.210
 ≥ 60 (years) 53 14 39 18 35 51 2
Gender
 Male 34 10 24 0.448 9 25 0.393 31 3 0.673
 Female 54 12 42 19 35 51 3
Histology
 Squamous carcinoma 35 6 29 0.167 16 37 0.686 32 3 0.679
 Adenocarcinoma 53 16 37 12 23 50 3
Differentiation
 Well 30 9 21 0.436 9 21 0.792 29 1 0.659
 Moderate/poor 58 13 45 19 39 53 5
TNM stage
 I+ II 34 15 19 0.001 19 15 <0.001 34 0 0.078
 III 54 7 47 9 45 48 6
Lymph node metastasis
 Yes 19 11 8 <0.001* 13 6 <0.001 18 1 1.000
 No 69 11 58 15 54 64 5

RASSF7, Ras-association domain family 7; TNM, tumor-node-metastasis.